【Introduction】
Product Name: Human Amyloid Beta Antibody (U.Zurich patent anti-Amyloid Beta, Research Use)
Catalog Number: NBR-0918
Target Name: Amyloid Beta
Trade Name: U.Zurich patent anti-Amyloid Beta
Antibody Drug Description: The drug is a recombinant fully human anti-Amyloid Beta monoclonal antibody, being developed by U.Zurich.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: APP
Synonyms: AD1
Target Description: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis 1.
Ensembl: ENSG00000142192
Uniprot: P05067